Skip to content

Is K2 MK-7 good for the heart? Unveiling the cardiovascular benefits

4 min read

Functional vitamin K insufficiency affects a large portion of the population, leading to the under-activation of key proteins vital for cardiovascular health. This article explores the compelling research showing how K2 MK-7 is good for the heart by actively regulating calcium and preventing the hardening of arteries.

Quick Summary

Studies show K2 MK-7 may benefit the heart by activating proteins that prevent arterial calcification and improve vascular elasticity. Observational and clinical trial data suggest a correlation between higher K2 intake and lower cardiovascular disease risk.

Key Points

  • Activates MGP: K2 MK-7 activates Matrix Gla Protein (MGP), a potent inhibitor that prevents calcium from depositing in soft tissues like arteries, keeping them flexible.

  • Reduces Arterial Stiffness: By preventing calcification, supplementation with K2 MK-7 has been shown to reduce age-related arterial stiffening in clinical trials.

  • Lower CVD Risk: Observational studies like the Rotterdam Study link higher dietary intake of K2 MK-7 to a significantly reduced risk of coronary heart disease mortality.

  • Superior to K1: K2 MK-7 has a longer half-life and better bioavailability than K1, allowing it to distribute more effectively to cardiovascular tissues.

  • Consult a Doctor for Anticoagulants: Individuals on blood-thinning medications like warfarin should consult a healthcare provider before taking K2 MK-7, as it can interfere with their treatment.

In This Article

The Role of Vitamin K2 in Cardiovascular Health

Vitamin K is a family of fat-soluble vitamins, primarily known for its role in blood clotting. However, it exists in two main forms: K1 (phylloquinone), found in leafy greens, and K2 (menaquinone), found in fermented foods and animal products. Among the various subtypes of K2, MK-7 (menaquinone-7) has gained significant attention for its superior bioavailability and longer half-life, which allows it to more effectively reach extrahepatic tissues, including blood vessels. The mounting evidence suggests that maintaining optimal levels of K2 MK-7 is crucial for long-term cardiovascular well-being.

How K2 MK-7 Protects Your Arteries

The primary mechanism through which K2 MK-7 benefits the heart is by regulating calcium metabolism. Its role is centered on activating specific vitamin K-dependent proteins (VKDPs) that control where calcium is deposited in the body.

  • Activation of Matrix Gla Protein (MGP): MGP is a potent inhibitor of soft-tissue calcification. In its inactive, uncarboxylated state (dp-ucMGP), MGP cannot effectively prevent calcium from accumulating in the arterial walls. K2 MK-7 acts as a cofactor for the enzyme gamma-glutamyl carboxylase, which converts inactive MGP into its active, carboxylated form. This activated MGP binds to free-floating calcium, preventing it from forming hard plaques that lead to arterial hardening and atherosclerosis. Studies have shown that elevated levels of inactive MGP are associated with higher arterial stiffness and increased cardiovascular mortality.
  • Improved Arterial Elasticity: By preventing and potentially even reversing arterial calcification, K2 MK-7 helps maintain the elasticity and distensibility of blood vessels. Clinical trials have shown that supplementation with K2 MK-7 can lead to a decrease in age-related arterial stiffening. This effect can improve pulse wave velocity, a marker of arterial health, which has been shown to decrease in supplementation groups.
  • Reduced Inflammation: Some research suggests that K2 MK-7 may possess anti-inflammatory properties, which can help combat the chronic inflammation often associated with atherosclerosis. By modulating specific signaling pathways, K2 MK-7 helps to suppress pro-inflammatory mediators.

The Scientific Evidence: Key Studies and Findings

Numerous studies, from large observational cohorts to randomized controlled trials, have investigated the link between K2 MK-7 and heart health.

  • The Rotterdam Study: A large, prospective population study observed 4,807 healthy men and women over ten years. It found that a high dietary intake of vitamin K2 (specifically MK-7, MK-8, and MK-9) was associated with a significantly reduced risk of severe aortic calcification and coronary heart disease mortality, an effect not observed with vitamin K1 intake.
  • The Prospect-EPIC Study: This cohort study of over 16,000 women found that for every unit of dietary vitamin K2 consumed per day, the risk of coronary heart disease showed a reduction.
  • The AVADEC Trial: This randomized controlled trial investigated K2 MK-7 and D3 supplementation on coronary artery calcification (CAC) progression. While no significant effect was seen in the total group, a sub-group analysis of participants at high risk for CAC showed a significant slowing of progression. These high-risk individuals also experienced fewer major cardiovascular events, suggesting a targeted benefit.

How K2 MK-7 Stacks Up: K1 vs. K2 MK-7

Feature Vitamin K1 (Phylloquinone) Vitamin K2 MK-7 (Menaquinone-7)
Primary Source Leafy green vegetables (e.g., kale, spinach) Fermented foods (e.g., natto, cheese), some animal products
Absorption Generally poorly absorbed from food sources (low bioavailability) Better absorbed, especially when consumed with fats
Half-Life Short (~1-2 hours) Long (~72 hours)
Tissue Distribution Primarily concentrated in the liver Distributed more widely to extrahepatic tissues, including blood vessels and bone
Main Function Primarily involved in blood coagulation Involved in calcium metabolism, bone health, and heart health
Key Heart Benefit Some evidence for correlation, but less strong than K2 Strong evidence for reducing arterial calcification and stiffness

K2 MK-7 and Safety Considerations

K2 MK-7 is generally well-tolerated and is not known to have a toxic level. The World Health Organization has not set a maximum intake level for vitamin K. However, individuals on blood-thinning medications, such as warfarin, must exercise extreme caution. Vitamin K directly interferes with these medications, and supplementation should only be done under strict medical supervision. Consulting with a healthcare provider is essential before starting any new supplement regimen, especially with pre-existing conditions or other medications.

Food Sources Rich in K2 MK-7

For those who prefer a dietary approach, incorporating certain foods can increase your K2 MK-7 intake. Some of the richest sources include:

  • Natto: A traditional Japanese dish of fermented soybeans, natto is exceptionally high in K2 MK-7.
  • Certain Cheeses: Hard cheeses like Gouda and soft cheeses like blue cheese contain significant amounts of menaquinones.
  • Sauerkraut: A fermented cabbage dish that contains K2 MK-7.
  • Animal Products: Though generally lower in K2 MK-7 than fermented foods, some animal products like chicken liver and egg yolks can contribute to overall intake.

Conclusion

The scientific evidence, though evolving, strongly indicates that K2 MK-7 plays a crucial protective role in cardiovascular health. Its unique ability to activate Matrix Gla Protein effectively regulates calcium metabolism, preventing the dangerous buildup of calcium in arterial walls. By inhibiting calcification and improving arterial elasticity, K2 MK-7 addresses a fundamental mechanism contributing to heart disease. While more long-term, large-scale controlled trials are needed, particularly concerning its effect on delaying valve calcification, the collective body of research is promising. For most people, incorporating K2 MK-7 through diet or safe supplementation may be a valuable strategy for supporting long-term heart health. As always, a personalized approach in consultation with a medical professional is recommended, especially for those on medication.

For more detailed information on the biological functions of Vitamin K, you can visit the National Institutes of Health website at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596038/.

Frequently Asked Questions

The main role of K2 MK-7 is to activate Matrix Gla Protein (MGP), which prevents calcium from accumulating in arterial walls and soft tissues, thus keeping arteries flexible and healthy.

K2 MK-7 serves as a cofactor for the enzyme that carboxylates MGP. This activates MGP, enabling it to bind to free calcium in the bloodstream and prevent its deposit in the arteries, which causes calcification.

Yes, research suggests K2 MK-7 is more beneficial for heart health than K1. K2 MK-7 has a much longer half-life and is more effectively transported to extrahepatic tissues, including the arteries, compared to K1.

While the optimal intake can vary, several studies investigating K2 MK-7 for cardiovascular and bone health have used varying amounts. Consulting with a healthcare professional can help determine an appropriate approach for individual needs.

While it is possible, a typical Western diet contains insufficient amounts of K2 MK-7 for full activation of all vitamin K-dependent proteins. Food sources like natto contain high amounts, but fermented foods and animal products are not regularly consumed in high enough quantities by many.

K2 MK-7 is generally considered safe and well-tolerated. No toxic level has been established. Some rare, mild side effects may include upset stomach or diarrhea. However, people on blood-thinners must seek medical advice before taking it.

The most potent source is natto (fermented soybeans). Other good dietary sources include certain hard and soft cheeses, sauerkraut, chicken liver, and other fermented foods.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.